Glumetza Buyers Get Cert. In Suit Over 800% Price Jump

By Dorothy Atkins · August 17, 2020, 7:04 PM EDT

A California federal judge on Friday certified a proposed class of diabetes drug buyers who accuse drugmakers of violating antitrust laws by blocking a generic version of Glumetza, saying it will...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re Glumetza Antitrust Litigation

Case Number

3:19-cv-05822

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

September 18, 2019